STAT3 and neoplasm: Tan et al. reported that the CRPC tumor cells exhibited decreased CKβBP2/CRIF1 expression relative to the levels observed in androgen-dependent PCA tumor cells, with a corresponding increase in the expression of the co-activator STAT3, contributing to synergistic AR signaling enhancement [58].